Expert NetworkExpert InterviewUCBJF

Slingshot members are talking to an expert! The topic is:

Discussing UCB's (Neurona Therapeutics) NRTX-1001 (Allogeneic Cell Therapy) for Drug-Resistant Epilepsy and the Phase 1/2 Data Presented at AAN 2026

Executed on:Apr 23, 2026 6:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Yale University
  • Professor of Clinical Neurology and Interim director of Epilepsy Monitoring Unit at Yale Medical School
  • Treats 500 adult patients with epilepsy and 600 patients with focal onset seizures per year
  • Research interest in new therapies for epilepsy using anticonvulsant medications and devices to treat patients with refractory epilepsy, neuromodulation, surgical treatment of seizure disorders, invasive electroencephalogram (EEG) techniques, intracranial EEG, and intraoperative EEG mapping.

Interview Goal

To gain a deeper understanding of NRTX-1001 (Allogeneic GABAergic Interneuron Cell Therapy) as a potential treatment for Drug-Resistant Epilepsy 

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.